A Study on Clinical Characteristics and The Impact Of Covid-19 In Hemodialysis Patients

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume : 03 | Issue : 02 | Page :
    By

    Towseef Ahmad Sofi,

  • Ibtisam Nazir Khan,

  • Pankaj Kaul,

  1. Student, Department of Allied & Health Sciences, Rayat Bahra University, Mohali, Punjab, India
  2. Assistant Professor, Department of Allied & Health Sciences, Rayat Bahra University, Mohali, Punjab, India
  3. Dean, Department of Allied & Health Sciences, Rayat Bahra University, Mohali, Punjab, India

Abstract

Background: The Corona Viruses Disease-19 pandemic has severely impacted Hemodialysis patients, who are vulnerable due to compromised immune systems and underlying comorbidities. Frequent Dialysis center visits increase their exposure risk to severe acute respiratory syndrome- Coronavirus Disease, and chronic inflammation, uremia, and immunosenescence may impair their immune response. Methods: This retrospective study included 60 Hemodialysis patients diagnosed with COVID-19 between January -July 2024. Data on demographics, clinical characteristics, laboratory results and outcomes were collected from electronic medical records. Patients were followed until recovery or death. Descriptive statistics and logistic regression analysis were applied to determine the risk factors associated with severe disease and mortality. Results: 15 patients (25%) presented with asymptomatic or mild symptoms, 12 patients (20%) exhibited moderate symptoms, and 19 patients (31.66%) developed severe symptoms. A total of 22 patients (36.66%) did not require admission for severe care, while 7 patients (11.66%) accounted for mortality cases. Risk factors for both severe COVID-19 and mortality were advanced age; number of comorbidities; cardiovascular diseases; increased levels of aspartate transaminase, lactate dehydrogenase, blood urea nitrogen/creatinine ratio, brain natriuretic peptide, and red cell distribution and decreased levels of hematocrit and albumin. Moreover, the number of COVID-19 vaccinations was a protective factor against both severe disease and mortality. Conclusion: COVID-19 in Hemodialysis patients is associated with high morbidity and mortality. Early recognition, isolation and aggressive management are crucial to improving outcomes in this vulnerable population.

Keywords: COVID-19, Hemodialysis, clinical characteristics, outcomes, mortality.

[This article belongs to International Journal of Biomedical Innovations and Engineering ]

How to cite this article:
Towseef Ahmad Sofi, Ibtisam Nazir Khan, Pankaj Kaul. A Study on Clinical Characteristics and The Impact Of Covid-19 In Hemodialysis Patients. International Journal of Biomedical Innovations and Engineering. 2025; 03(02):-.
How to cite this URL:
Towseef Ahmad Sofi, Ibtisam Nazir Khan, Pankaj Kaul. A Study on Clinical Characteristics and The Impact Of Covid-19 In Hemodialysis Patients. International Journal of Biomedical Innovations and Engineering. 2025; 03(02):-. Available from: https://journals.stmjournals.com/ijbie/article=2025/view=233242


References

1.      Alberici F, Delbarba E, Manenti C, et al. Management of patients on dialysis and with kidney transplant during SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep. 2020;5(5):580–585.
2.      Bahat K, Parmaksiz E, Sert S. The clinical characteristics and course of COVID-19 in hemodialysis patients. Hemodial Int. 2020;24(4):534–540.
3.      Basile C, Combe C, Pizzarelli F. Recommendations for the prevention, mitigation, and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centers. Nephrol Dial Transplant. 2020;35(5):737–741.
4.      Chen B, Song Y, Li R, Pei S. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368(6490):489–493.
5.      Gorayeb-Polacchini FS, Caldas HC, Abbud-Filho M. Clinical outcomes of COVID-19 in patients undergoing chronic hemodialysis and peritoneal dialysis. Brazilian Journal of Nephrology [Internet]. 2022 May 25;44(4):505–10. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9838679/ ‌
6.      Daugirdas JT, Blake PG, Ing TS. Handbook of Dialysis. 4th ed. New York: Lippincott Williams & Wilkins; 2007. p. 66–67.
7.      Goicoechea M, Cámara LA, Macías N, et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020;98(1):27–34.
8.      Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020;52(6):1193–1194.
9.      Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
10.  Khossroshahi TH, Mardomi A, Niknafs B, et al. Current status of COVID-19 among hemodialysis patients in the East Azerbaijan Province of Iran. Hemodial Int. 2020;24(4):1–6.
11.  Kikuchi K, Nangaku M, Ryuzaki M. COVID-19 in dialysis patients in Japan: Current status and guidance on preventive measures. Ther Apher Dial. 2020;24(4):361–365.
12.  Kooman JP, van der Sande FM. COVID-19 in ESRD and acute kidney injury. Blood Purif. 2021;50(4–5):610–620.
13.  Ma Y, Diao B, Lv X, et al. 2019 novel coronavirus disease in hemodialysis patients: Report from one HD center in Wuhan, China. Am J Kidney Dis. 2020;76(1):141–143.
14.  McKellar S, Gordon A. The artificial kidney in Canada. Nephrol Dial Transplant. 1999;14(11):2766–2770.
15.  Monaghan C, Larkin JW, Chaudhuri S, et al. Artificial intelligence for COVID-19 risk classification in kidney disease: Can technology unmask an unseen disease? medRxiv. 2020; Available from: https://doi.org/10.1101/2020.06.12.20129501
16.  Pickering JW, Endre ZH. Baseline creatinine: Where to from here? Nephrol Dial Transplant. 2011;26(7):2056–2057.
17.  Tian M, Li H, Yan T, et al. Clinical features of patients undergoing hemodialysis with COVID-19. Nephrol Dial Transplant. 2020;25(8):929–930.
18.  Trivedi M, Shingada A, Shah M. Impact of COVID-19 on maintenance hemodialysis patients: The Indian scenario. Nephrology. 2020;25(9):929–939.
19.  Trujillo H, Caravaca-Fontán F, Sevillano Á, et al. SARS-CoV-2 infection in hospitalized patients with kidney disease. Kidney Int Rep. 2020;5(6):905–909.
20.  Xie X, Zhong Z, Zhao W, et al. Chest CT for typical 2019-nCoV pneumonia: Relationship to negative RT-PCR testing. Radiology. 2020;292(2):E41–E45.
21.  Khossroshahi TH, Mardomi A, Niknafs B, et al. COVID-19 in hemodialysis patients in Iran: Current status and strategies. Hemodial Int. 2020;24(4):1–6.
22.  Aydin Bahat K, Parmaksiz E, Sert S. The clinical characteristics and course of COVID‐19 in hemodialysis patients. Hemodialysis International. 2020 Aug 2;24(4):534–40. Available from: https://pubmed.ncbi.nlm.nih.gov/32730678/.

Regular Issue Subscription Original Research
Volume 03
Issue 02
Received 25/03/2025
Accepted 06/09/2025
Published 29/11/2025
Publication Time 249 Days
34

Login


My IP

PlumX Metrics